WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
-1.94%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$1.73B
AUM Growth
+$1.73B
(+33%)
Cap. Flow
+$777M
Cap. Flow
% of AUM
44.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
4
Reduced
–
Closed
–
Top Buys
| 1 |
RAI
Reynolds American Inc
RAI
|
$407M |
| 2 |
AbbVie
ABBV
|
$287M |
| 3 |
Prothena Corp
PRTA
|
$30.6M |
| 4 |
Alkermes
ALKS
|
$25.1M |
| 5 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
$23.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 58.06% |
| 2 | Consumer Staples | 41.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAI
1
DELISTED
Reynolds American Inc
RAI
| $726M | 41.94% | 16,407,290 +9,186,145 | +127% | +$407M |
|
|
2
Alkermes
ALKS
$4.78B
| $305M | 17.64% | 5,206,633 +428,000 | +9% | +$25.1M |
|
|
3
AbbVie
ABBV
$372B
| $287M | 16.58% | +5,277,800 | New | +$287M |
|
|
4
Prothena Corp
PRTA
$441M
| $281M | 16.24% | 6,202,525 +675,000 | +12% | +$30.6M |
|
|
NWBO
5
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $128M | 7.38% | 20,461,392 +3,740,000 | +22% | +$23.4M |
|
6
Theravance Biopharma
TBPH
$699M
| $3.96M | 0.23% | +360,685 | New | +$3.96M |
|